Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells

被引:71
作者
Eurich, Katrin [1 ]
Segawa, Mayuko [1 ]
Toei-Shimizu, Satoko [1 ]
Mizoguchi, Emiko [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Gastrointestinal Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA
关键词
Mammals; Chitinase; 3-like; 1; Colon; Epithelial cells; Inflammation; Colitis; Colon neoplasms; Inflammatory bowel disease; HUMAN CARTILAGE GLYCOPROTEIN-39; ACIDIC MAMMALIAN CHITINASE; SERUM YKL-40 LEVEL; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; CHITOTRIOSIDASE ACTIVITY; HUMAN-PAPILLOMAVIRUS; ULCERATIVE-COLITIS; CERVICAL-CANCER;
D O I
10.3748/wjg.15.5249
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The family of mammalian chitinases includes members both with and without glycohydrolase enzymatic activity against chitin, a polymer of N-acetylglucosamine. Chitin is the structural component of fungi, crustaceans, insects and parasitic nematodes, but is completely absent in mammals. Exposure to antigens containing chitin- or chitin-like structures sometimes induces strong T helper type-I responses in mammals, which may be associated with the induction of mammalian chitinases. Chitinase 3-like-1 (CHI3L1), a member of the mammalian chitinase family, is induced specifically during the course of inflammation in such disorders as inflammatory bowel disease, hepatitis and asthma In addition, CHI3L1 is expressed and secreted by several types of solid tumors including glioblastoma, colon cancer, breast cancer and malignant melanoma. Although the exact function of CHI3L1 in inflammation and cancer is still largely unknown, CHI3L1 plays a pivotal role in exacerbating the inflammatory processes and in promoting angiogenesis and remodeling of the extracellular matrix. CHI3L1 may be highly involved in the chronic engagement of inflammation which potentiates development of epithelial tumorigenesis presumably by activating the mitogen-activated protein kinase and the protein kinase B signaling pathways. Anti-CHI3L1 antibodies or pan-chitinase inhibitors may have the potential to suppress CHI3L1-mediated chronic inflammation and the subsequent carcinogenic change in epithelial cells. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:5249 / 5259
页数:11
相关论文
共 194 条
[1]   Transglycosidase activity of chitotriosidase - Improved enzymatic assay for the human macrophage chitinase [J].
Aguilera, B ;
Ghauharali-van der Vlugt, K ;
Helmond, MTJ ;
Out, JMM ;
Donker-Koopman, WE ;
Groener, JEM ;
Boot, RG ;
Renkema, GH ;
van der Marel, GA ;
van Boom, JH ;
Overkleeft, HS ;
Aerts, JMFG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40911-40916
[2]   Mechanisms of Disease:: chronic inflammation and cancer in the pancreas -: a potential role for pancreatic stellate cells? [J].
Algfuel, Hana ;
Treiber, Matthias ;
Lesina, Marina ;
Schmid, Roland M. .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (08) :454-462
[3]  
Ardies C Murray, 2003, Integr Cancer Ther, V2, P238, DOI 10.1177/1534735403256332
[4]   Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer [J].
Atreya, R. ;
Neurath, M. F. .
CURRENT DRUG TARGETS, 2008, 9 (05) :369-374
[5]   Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer [J].
Atreya, R ;
Neurath, MF .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) :187-195
[6]   Potential Role of Human Papillomavirus in the Development of Subsequent Primary In Situ and Invasive Cancers Among Cervical Cancer Survivors [J].
Balamurugan, Appathurai ;
Ahmed, Faruque ;
Saraiya, Mona ;
Kosary, Carol ;
Schwenn, Molly ;
Cokkinides, Vilma ;
Flowers, Lisa ;
Pollack, Lori A. .
CANCER, 2008, 113 (10) :2919-2925
[7]  
Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021
[8]   PANCREATITIS IS A RISK FACTOR FOR PANCREATIC-CANCER [J].
BANSAL, P ;
SONNENBERG, A .
GASTROENTEROLOGY, 1995, 109 (01) :247-251
[9]  
Barone R, 2007, CLIN LAB, V53, P321
[10]   Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma - A clinical, phase 1/2 trial [J].
Berntsen, Annika ;
Trepiakas, Redas ;
Wenandy, Lynn ;
Geertsen, Poul F. ;
Straten, Per thor ;
Andersen, Mads H. ;
Pedersen, Anders E. ;
Claesson, Mogens H. ;
Lorentzen, Torben ;
Johansen, Julia S. ;
Svane, Inge Marie .
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) :771-780